Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride improved both hair loss and acne in two young men.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Androgens can both increase body hair and cause scalp hair loss.

Finasteride cream reduces hair growth in women with hirsutism, but more research needed.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

Spironolactone helps regrow hair in women with hair loss.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

The spironolactone cream did not reduce hair growth in women with hirsutism.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Finasteride and metformin both help treat PCOS, but using them together works best.

Severe acne in a young girl may indicate underlying hormonal issues.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

IPM enhances skin penetration of hydrophilic drugs.

Male and female skin differ in many ways, which could lead to gender-specific skin treatments.

Hair loss in men is common, treatable, but not curable.

Acne treatment varies, with topical and systemic therapies effective, and more research needed on treatment order and long-term effects.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Chitosan-decorated polymersomes improve finasteride delivery for hair loss treatment.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Transcutol P best increases Finasteride absorption for hair loss treatment.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

The document concludes that various treatments, including laser therapy, are effective for managing pseudofolliculitis barbae, especially in darker skin types.

Laser hair removal is effective for dark hair but needs improvement for nonpigmented or fine hairs.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

The document explains that hirsutism, often caused by hormonal issues, can be managed with treatment to improve both physical appearance and mental health.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Secondary aesthetic surgeries for gender reassignment are generally satisfying and advance overall aesthetic surgery techniques, but psychological support is important.

Granules improve hair loss treatment by targeting follicles.